EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

21.50p
   
  • Change Today:
      0.100p
  • 52 Week High: 33.20p
  • 52 Week Low: 18.75p
  • Currency: UK Pounds
  • Shares Issued: 452.11m
  • Volume: 83,218
  • Market Cap: £97.20m

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.
Competitors: Physiomics, SDI Group , Polarean Imaging
Registrars: Capita Registrars

Key Personnel

CEO: Gavin T Jones
CFO: Stephen (Steve) Young
Executive Chairman: Julian Baines
Senior Independent Director: Christian Alexander Rigg
Non-Executive Dir: Jenny Winter, Christopher H B Mills

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 20 710570
Fax: +44 (0)29 20 705715
Website: http://www.ekfdiagnostics.com

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB0031509804

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 21.50p
Change Today 0.100p
% Change 0.47 %
52 Week High 33.20p
52 Week Low 18.75p
Volume 83,218
Shares Issued 452.11m
Market Cap £97.20m

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
79.59% below the market average79.59% below the market average79.59% below the market average79.59% below the market average79.59% below the market average
74.26% below the sector average74.26% below the sector average74.26% below the sector average74.26% below the sector average74.26% below the sector average
Price Trend
49.91% below the market average49.91% below the market average49.91% below the market average49.91% below the market average49.91% below the market average
57.01% below the sector average57.01% below the sector average57.01% below the sector average57.01% below the sector average57.01% below the sector average
Income Not Available
Growth
57.90% above the market average57.90% above the market average57.90% above the market average57.90% above the market average57.90% above the market average
50.54% above the sector average50.54% above the sector average50.54% above the sector average50.54% above the sector average50.54% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 30-Apr-2025

Time Volume / Share Price
16:35 4,308 @ 21.50p
16:35 419 @ 21.50p
16:35 1,077 @ 21.50p
16:35 1,159 @ 21.50p
16:35 170 @ 21.50p

EKF Key Personnel

CFO Stephen (Steve) Young
CEO Gavin T Jones

Top of Page